Rani Therapeutics Holdings, Inc. (RANI) Tops Q1 EPS by 2c

Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) reported Q1 EPS of ($0.22), $0.02 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $172 thousand.

For earnings history and earnings-related data on Rani Therapeutics Holdings, Inc. (RANI) click here.

You May Also Be Interested In

• OpenAI: after the Hugging Face incident, we committed to conducting a much broader review of actions taken by our models
• NV Gold closes final tranche of private placement, raising $1.4M
• BofA raises AMD target to $720, sees server CPU TAM tripling to $211B by 2030